Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Higher Field Strengths and New Clinical Applications Increase Growth of MRI Systems

By MedImaging staff writers
Posted on 27 Jun 2007
Magnetic resonance imaging (MRI) is one of the most powerful and widely used diagnostic tools by clinicians today. More...
However, there are many challenges such as increasing pricing pressures, regulatory issues, and competition from computed tomography (CT) that need to be overcome in the European MRI systems market, according to a recent marketing report.

Despite these challenges, the market is expected to see growth. The scope for growth is related to the introduction of new applications. The market is not yet saturated and there are a few unexplored niche segments, which offer huge growth potential. Frost & Sullivan (Palo Alto, CA, USA), an international growth consultancy company, found that the European MRI market earned revenues of US$806.5 million in 2006 and estimates this to reach $1.03 billion in 2013.

"The European MRI systems market is primarily driven by the current wide variety of applications and constant development of new ones,” noted Frost & Sullivan research analyst B. Divya. "With continued upgrades in Tesla strength, the number of applications using MRI is increasing from the research point of view and is also becoming increasingly commercially viable.”

With advancements in neurologic, cardiac, and vascular, as well as breast MRI, the market is seeing growth essentially due to the application potential. Each new clinical application increases the usage of MRI systems. Moreover, high-field systems are expected to continue demonstrating strong growth, thereby replacing low-field systems.

However, the current state of the European healthcare system is restraining market growth. In addition, differing reimbursement policies in various geographic regions in the European Union are still another challenge. Furthermore, there is also the inherent challenge arising due to competition from CT.

"The European healthcare industry is experiencing severe financial constraints from having to support an aging population, with contributions from a small portion of working population,” explained Ms. Divya. "Consequently, the governments of various nations are wary of the fact that healthcare spending is exceedingly high, and one of the interesting ways in which nations are reducing healthcare costs is by simply not buying additional equipment.”

As the market is heading toward saturation, market participants will need to concentrate on niche segments. Targeting niche markets can be either through the acquisition of existing small local participants or through the introduction of new products.


Related Links:
Frost & Sullivan

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.